Hasbani NR, Righart S, Brown MR, Heath AS, Bebo A, Ashley KE, Bowinkle E, Morrison AC, Folsom AR, Aguilar D, de Vries PS. American Heart Association’s life’s simple 7: Lifestyle recommendations, polygenic risks, and lifetime risk of coronary heart disease. Circulation. 2022;145(11):808–18.

Article PubMed PubMed Central Google Scholar

Luo W, Cao L, Wang C. Hypothermia and mortality in critically ill patients with coronary heart disease: A retrospective analysis from the MIMIC-IV database. Eur J Med Res. 2023;28(1):614.

Article PubMed PubMed Central Google Scholar

Mayer VD, Dünser MW, Grail V, Jochberger S, Lückner G, Ulmer H, Friesenecker BE, Takara J, Hasibeder WR. Determinants of causes of death and outcome in critically ill patients. Critical Care (London, UK). 2006;10(6):R154.

Article Google Scholar

Wang Y, O’Neil A, Jiao Y, Wang L, Huang J, Lan Y, Zhu Y, Yu C. Gender differences in the association of diabetes with risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: 5,162,654 Systematic review and meta-analysis of human participants. BMC Medicine. 2019;17(1):136.

Article PubMed PubMed Central Google Scholar

Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for developing coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetes mellitus. 2014;57(8):1542–51.

Article PubMed Google Scholar

Natali A, Vichi S, Landi P, Severi S, L’Abbate A, Ferrannini E. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetes mellitus. 2000;43(5):632–41.

Article CAS PubMed Google Scholar

Malik S, Wong ND, Franklin SS, Camas TV, Ritarian GJ, Pio JR, Williams GR. Impact of metabolic syndrome on coronary heart disease, cardiovascular disease, and all-cause mortality among U.S. adults. Circulation. 2004;110(10):1245–50.

Article PubMed Google Scholar

Verma S, Mather CD, Yang AT, Mason T, Garg V, Teoh H, Zuo F, Quan A, Falkow ME, Fitchett DH, Goodman SG, Goldenberg RM, Al-Omran M, Gilbert RE, Butt DL, Reiter LA, Juni. P, Zinman B, Connelly KA. Effect of empagliflozin on left ventricular masses in patients with type 2 diabetes and coronary artery disease: EMPA-HEART CardioLink-6 randomized clinical trial. Circulation. 2019;140(21):1693–702.

Article PubMed Google Scholar

Sarak B, Verma S, David Mather C, Teo H, Quan A, Gilbert RE, Goodman SG, Bami K, Coelho-Filho OR, Ahuja V, Deva DP, Garg V, Gandhi S, Connelly KA, Yang AT. Effects of empagliflozin on right ventricular parameters and function in patients with type 2 diabetes. Cardiovascular diabetes. 2021;20(1):200.

Article CAS PubMed PubMed Central Google Scholar

Yang G, Au Yong SL, Schooling CM. Gender differences in the association between fasting blood glucose and HbA1c and its impact on mortality: a Mendelian randomized study. E-biomedicine. 2022;84:104259.

Article CAS PubMed PubMed Central Google Scholar

Van Steen SC, Woodward M, Chalmers J, Lee Q, Mahle M, Cooper ME, Hammett P, Mancia G, Collagiuri S, Williams B, Grobbie DE, DeVries JH. Hemoglobin glycation index and risk of diabetes-related complications in diabetes and vascular disease: the Preterax and Diamicron Modified Controlled Release Evaluation (ADVANCE) study. Diabetes mellitus. 2018;61(4):780–9.

Article PubMed PubMed Central Google Scholar

Hempe JM, Gomez R, McCarter RJ Jr., Chalu SA. Hyper- and hypo-hemoglobin glycation phenotypes in type 1 diabetes: Challenges in interpreting glycemic control. J Complications of Diabetes. 2002;16(5):313–20.

Article Google Scholar

Malka R, Nathan DM, Higgins JM. Mechanistic modeling of hemoglobin glycosylation and red blood cell dynamics enables personalized diabetes monitoring. Science translation medicine. 2016;8(359):359ra130.

Article PubMed PubMed Central Google Scholar

Kela PK, Joyner CH, Carruthers A, Linsell CJ, Smith EP, Franco RS, Holmes YR, Cohen RM. Evidence for interindividual heterogeneity in glucose gradients across human red blood cell membranes and their relationship to hemoglobin glycosylation. Diabetes mellitus. 2008;57(9):2445–52.

Article CAS PubMed PubMed Central Google Scholar

Brown SM, Smith DM, Ort N, Thorpe SR, Baines JW. Tissue-specific variations in protein glycosylation in diabetes: Evidence for a functional role for the amadoriase enzyme. Volume 1043. Annals of the New York Academy of Sciences. 2005. Pages 817–23.

Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. Hemoglobin glycation index identifies subpopulations that may be harmed or benefited from intensive care in the ACCORD trial. diabetes care. 2015;38(6):1067–74.

Article CAS PubMed PubMed Central Google Scholar

Klein KR, Franek E, Marso S, Peever TR, Pratley RE, Gowda A, Qvist K, Busse JB. Hemoglobin glycation index calculated from a single fasting blood glucose value as a predictive tool for severe hypoglycemia and serious adverse cardiovascular events in DEVOTE. Volume 9. BMJ Open Diabetes Research and Care. 2021.2．

Wang Y, Liu H, Hu Associated cardiovascular events: The REACTION cohort study. Chin Med J. 2023;136(20):2468–75.

Article CAS PubMed PubMed Central Google Scholar

Pan Y, Jing J, Wang Y, Liu L, Wang Y, He Y. Association between hemoglobin glycation index and acute ischemic stroke outcome in patients with type 2 diabetes. Neurol Test 2018;40(7):573–80.

Article PubMed Google Scholar

Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetic metabolic syndrome. 2019;13(2):1449–55.

Article PubMed Google Scholar

Lyu L, Yu J, Liu Y, He S, Zhao Y, Qi M, Ping F, Xu L, Li W, Zhang H, Li Y. High hemoglobin glycation index is mediated by TNFα independently of HbA1c. associated with a decrease in telomeres. J Clin Endocrine Meta Tab. 2022;107(2):462–73.

Article PubMed Google Scholar

Johnson AEW, Bulgaria L, Shen L, Gales A, Shamout A, Horn S, Pollard TJ, Hao S, Moody B, Gau B, Lehman LH, Selly LA, Mark RG. MIMIC-IV, a freely accessible electronic health record dataset. scientific data. 2023;10(1):1.

Article CAS PubMed PubMed Central Google Scholar

Cheng Y, Chen Y, Mao M, Wang R, Zhu J, He Q. Association between inflammatory indicators and intensive care unit mortality in critically ill patients with coronary heart disease. Front Immunol. 2023;14:1295377.

Article CAS PubMed PubMed Central Google Scholar

Chen Z, Li D, Lin M, Jiang H, Xu T, Shan Y, Fu G, Wang M, Zhang W. Association between hemoglobin glycation index and contrast agent-induced acute kidney injury in patients undergoing coronary angiography: Retrospective study. front physical. 2022;13:870694.

Article PubMed PubMed Central Google Scholar

Yutaka Nakasone, Takashi Miyakoshi, Takashi Sakuma, Takashi Toda, Yutaka Yamada, Takashi Oguchi, Kazu Hirabayashi, Hiroshi Koike, Kazu Yamashita, and Takashi Aizawa. Hemoglobin glycation index, a new risk factor for the development of chronic kidney disease in an apparently healthy population. Journal of Clinical Endocrinology and Metabolism 2023.

Wang M, Li S, Zhang X, Li X, Cui J. Association between hemoglobin glycation index and nonalcoholic fatty liver disease in patients with type 2 diabetes. J Diabetes Investment. 2023;14(11):1303–11.

Article CAS Google Scholar

Bookchin RM, Gallop PM. Structure of hemoglobin Alc: Properties of the N-terminal beta chain blocking group. Biochem Biophys Res Commun. 1968;32(1):86–93.

Article CAS PubMed Google Scholar

McCarter RJ, Hempe JM, Gomez R, Charu SA. Biological variation in HbA1c predicts the risk of retinopathy and nephropathy in type 1 diabetes. diabetes care. 2004;27(6):1259–64.

Article CAS PubMed Google Scholar

Carette C, Czernichow S. Harms and benefits of the hemoglobin glycation index (HGI). Eur J Prev Cardiol. 2017;24(13):1402–4.

Article PubMed Google Scholar

Chen J, ying D, Dou K. Enhanced glycemic control with HbA1c for patients with coronary heart disease and type 2 diabetes: a review of findings and conclusions. Cardiovascular diabetes. 2023;22(1):146.

Article PubMed PubMed Central Google Scholar

You H, Hou X, Zhang H, Li X, Feng X, Qian X, Shi N, Guo R, Wang X, Sun H, Feng W, Li G, Zheng Z, Chen Y. Effects of glycemic control and glucose fluctuations on diabetes. In-hospital adverse outcomes after on-pump coronary artery bypass grafting in patients: a retrospective study. Diabetic metatab syndrome. 2023;15(1):20.

Article CAS PubMed PubMed Central Google Scholar

Riddle MC, Gerstein HC and others. Comments on Hempe Hemoglobin glycation index identifies subpopulations with harm or benefit from intensive care in the ACCORD trial. diabetes care. 2015;38:1067–1074. Diabetes Care 2015, 38 (10), e170-1.

Ahn CH, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Ha J, Sherman AS, Lim S. The hemoglobin glycation index is associated with cardiovascular risk in people with impaired glucose metabolism. associated with disease. J Clin Endocrine Meta Tab. 2017;102(8):2905–13.

Article PubMed PubMed Central Google Scholar

Meigs JB, Nathan DM, D’Agostino RB, Wilson S. Glycemia and cardiovascular disease risk during fasting and after challenge: a Framingham offspring study. diabetes care. 2002;25(10):1845–50.

Article PubMed Google Scholar

Gao S, Huang S, Lin X, Xu L, Yu M. Prognostic impact of stress hyperglycemia ratio in myocardial infarction patients with non-obstructed coronary arteries. Ann Med 2023;55(1):990–9.

Article CAS PubMed PubMed Central Google Scholar

Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, Wang W, Shao C, Tang YD. Impact of stress hyperglycemia ratio on short-term and long-term poor prognosis of acute coronary syndrome patients: Insights from a large cohort study in Asia. diabetes care. 2022;45(4):947–56.

Article CAS PubMed Google Scholar

Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress-induced hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. The Lancet (London, UK). 2000;355(9206):773–8.

Article CAS PubMed Google Scholar